Literature DB >> 12410093

The role of infectious agents in the pathogenesis of systemic sclerosis.

Damir Hamamdzic1, Laura M Kasman, E Carwile LeRoy.   

Abstract

Over the past few years, increasing evidence has accumulated to implicate infectious agents in the etiology of systemic sclerosis (SSc) and Raynaud phenomenon. Infection rates in patients with SSc compared with those in control populations do not provide clear support for any specific pathogen. However, increased antibody titers, a preponderance of specific strains in patients with SSc, and evidence of molecular mimicry inducing autoimmune responses suggest mechanisms by which infectious agents may contribute to the development and progression of SSc. Here we review studies examining the potential involvement of, cytomegalovirus, and parvovirus B19 in SSc pathogenesis.

Entities:  

Mesh:

Year:  2002        PMID: 12410093     DOI: 10.1097/00002281-200211000-00011

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  14 in total

1.  Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients.

Authors:  Manuela Indelicato; Valentina Chiarenza; Massimo Libra; Grazia Malaponte; Valentina Bevelacqua; Maurizio Marchini; James A McCubrey; Franca Stivala; Raffaella Scorza; Maria Clorinda Mazzarino
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?

Authors:  Mislav Radić; Dušanka Martinović Kaliterna; Damir Bonacin; Jadranka Morović Vergles; Josipa Radić; Damir Fabijanić; Vedran Kovačić
Journal:  Rheumatol Int       Date:  2012-12-06       Impact factor: 2.631

3.  Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis.

Authors:  Ikuko Hayakawa; Shinichi Sato; Takeshi Echigo; Fumiaki Shirasaki; Minoru Hasegawa; Kazuhiko Takehara
Journal:  Clin Rheumatol       Date:  2004-04-09       Impact factor: 2.980

Review 4.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

5.  Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives.

Authors:  Fabian A Mendoza; Maryah Mansoor; Sergio A Jimenez
Journal:  Expert Opin Orphan Drugs       Date:  2015-11-23       Impact factor: 0.694

6.  Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.

Authors:  Cinzia Scambi; Valentina La Verde; Lucia De Franceschi; Giovanni Barausse; Fabio Poli; Fabio Benedetti; Marco Sorio; Francesca Deriu; Paola Roncada; Oscar Bortolami; Francesco Turrini; Paola Caramaschi; Chiara Stranieri; Lisa M Bambara; Domenico Biasi
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

7.  High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis.

Authors:  Sarah T Arron; Michelle T Dimon; Zhenghui Li; Michael E Johnson; Tammara A Wood; Luzviminda Feeney; Jorge G Angeles; Robert Lafyatis; Michael L Whitfield
Journal:  J Invest Dermatol       Date:  2014-03-07       Impact factor: 8.551

8.  Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin.

Authors:  Michael E Johnson; Jennifer M Franks; Guoshuai Cai; Bhaven K Mehta; Tammara A Wood; Kimberly Archambault; Patricia A Pioli; Robert W Simms; Nicole Orzechowski; Sarah Arron; Michael L Whitfield
Journal:  Arthritis Res Ther       Date:  2019-02-06       Impact factor: 5.606

Review 9.  Amplification of autoimmune disease by infection.

Authors:  David N Posnett; Dmitry Yarilin
Journal:  Arthritis Res Ther       Date:  2005-02-10       Impact factor: 5.156

Review 10.  Possible role of human herpesvirus 6 as a trigger of autoimmune disease.

Authors:  Francesco Broccolo; Lisa Fusetti; Luca Ceccherini-Nelli
Journal:  ScientificWorldJournal       Date:  2013-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.